Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trial
Felice Rivellese(Queen Mary University of London), Raquel Celis, Alessandra Nerviani(Queen Mary University of London), Bernard Lauwerys(UCLouvain), Juan D. Cañete(Hospital Clínic de Barcelona), Edoardo Prediletto(Queen Mary University of London), Liliane Fossati‐Jimack, Julio Ramírez, Vasco C. Romão(University of Lisbon), Anna E. A. Surace(Queen Mary University of London), Carlomaurizio Montecucco(University of Pavia), Giovanni Giorli(Queen Mary University of London), Pier Paolo Sainaghi(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Hasan Rizvi(Queen Mary University of London), Alberto Cauli(University of Cagliari), Elisabetta Sciacca(Queen Mary University of London), Paul McKeigue(University of Edinburgh), S. Church(Nanostring Technologies (United States)), Maya H Buch(University of Manchester), João Eurico Fonseca, Myles Lewis(Brigham and Women's Hospital), Nagui Gendi(Basildon Hospital), Costantino Pitzalis(Guy's Hospital), Pauline Ho(Manchester Royal Infirmary), Bhaskar DasGupta(University of Cagliari), Christopher R. John(Queen Mary University of London), Cankut Çubuk(Queen Mary University of London), Sarah Warren(Nanostring Technologies (United States)), Patrick Durez(Cliniques Universitaires Saint-Luc), Briana M. Hudson(Nanostring Technologies (United States)), Patrick Verschueren(KU Leuven), Manzoor Ahmed(Queen Mary University of London), Stephen Kelly(Barts Health NHS Trust), Georgina Thorborn, Michael R. Barnes(GlaxoSmithKline (United Kingdom)), Piero Reynolds(Homerton University Hospital), Arti Mahto(King's College Hospital NHS Foundation Trust), Frances Humby(William Harvey Research Institute), Nora Ng(Guy's and St Thomas' NHS Foundation Trust), Katriona Goldmann(Queen Mary University of London)
Cited by 277
Related Papers
Defining inflammatory cell states in rheumatoid arthritis joint synovial tissues by integrating single-cell transcriptomics and mass cytometry
|Nature Immunology|2019|1.4k
Integrative Analyses of Colorectal Cancer Show Immunoscore Is a Stronger Predictor of Patient Survival Than Microsatellite Instability
|Immunity|2016|1.1k
SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and gout
|Nature Genetics|2008|806
EULAR definition of difficult-to-treat rheumatoid arthritis
|Annals of the Rheumatic Diseases|2020|538